The role of endothelial connexins in vascular wound repair
内皮连接蛋白在血管伤口修复中的作用
基本信息
- 批准号:10751730
- 负责人:
- 金额:$ 4.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-10 至 2026-02-09
- 项目状态:未结题
- 来源:
- 关键词:AlanineAntibodiesAortaAreaArteriesBiologicalBiologyBiomedical ResearchBlood VesselsC-terminalCarotid ArteriesCell CommunicationCell Culture TechniquesCell LineCell ProliferationCell SeparationCellsCessation of lifeCommunicationConfocal MicroscopyConnexin 43ConnexinsCoronary ThrombosisCoronary arteryDataData AnalysesDefectDeoxyuridineDiseaseEndothelial CellsEndotheliumEnsureEnvironmentEquipmentFailureFellowshipFemaleGap JunctionsGeneticGoalsHealthHeartHomeHourHumanImmunofluorescence ImmunologicImpaired healingImpairmentInjectionsInjuryInvestigationKnock-outKnockout MiceLegal patentLifeLigationLinkMeasuresMediatingMentorshipMicroscopeMissionModelingModernizationModificationMusMutationMyocardial InfarctionOperative Surgical ProceduresPathway interactionsPatientsPharmaceutical PreparationsPhosphorylationPhosphorylation InhibitionPhosphorylation SitePhosphotransferasesPlasmidsPost-Translational Protein ProcessingPreparationProcessProliferatingProliferation MarkerProto-Oncogene Proteins c-aktResearchResearch InstituteResearch PersonnelRoleSaphenous VeinSerineSignal PathwaySignal TransductionSiteStentsSurvival RateTechnical ExpertiseTechniquesTestingTherapeuticThrombusTissuesTrainingTransfectionTravelUnited States National Institutes of HealthUniversitiesUp-RegulationVascular DiseasesVascular Endothelial CellVascular GraftVirginiaWestern BlottingWorkanimal facilityburden of illnesscell growthcell injurycell motilitydesignendothelial regenerationendothelial repairexperienceexperimental studyhealingimprovedin vivoin vivo Modelinjuredmalemigrationmimeticsnovelpharmacologicprotein expressionrepairedresponserestenosissexstroke risktherapeutic targettranscriptome sequencingvascular injurywound closurewound healing
项目摘要
|| Project Summary .
Impaired endothelial wound healing in blood vessels like the coronary artery and saphenous vein is a primary
contributor to vascular stent failure and deadly coronary thrombosis. Identifying the mechanism of delayed
endothelial repair is essential for improving vessel patency and patient survival rates. As such, this proposal
focuses on identifying regulators of normal endothelial healing and understanding how these factors are
dysregulated when healing is impaired. Previous studies have shown connexin 43 (Cx43) gap junctions may
regulate wound healing. However, the specific role of connexin 43 in endothelial cell (EC) healing is unknown.
Preliminary data in this proposal indicates that ligation-induced vascular injury promotes increases in the
expression of EC Cx43 surrounding the damaged area in the aorta and carotid arteries in mice. Cx43-mediated
gap junction intracellular communication is controlled by phosphorylation at the Cx43 C-terminus. My preliminary
data demonstrate that specific Cx43 phosphorylation at its serine (s) 368, associated with gap junction closure,
is present during the final stages of EC wound healing in vivo. Cx43-s368 also reduced the rate of wound closure
in cultured human EC. These findings inform the hypothesis that Cx43 expression and channel functions are
critical for EC wound healing in large arteries. The aims of this proposal are to define the role of connexin 43 in
endothelial wound healing (Aim 1), investigate if a loss of Cx43 limits healing in vivo (Aim 1), and test if channel
functions, regulated by posttranslational modifications, improve/delay vascular repair (Aim 2). This investigation
will be completed using a novel mouse carotid EC injury survival surgery in mice I developed, which will allow
for the assessment of Cx43 expression in carotid EC during the healing process. Both genetic and
pharmacological strategies will be used to alter Cx43 expression and phosphorylation in mouse injury models
and in cultured human EC, and the impact of these modifications on the rate and quality of EC healing will be
quantified. Additionally, RNAseq approaches will be used to identify Cx43 gap junction-dependent signaling in
the regenerating endothelium. These aims will be accomplished under the mentorship of researchers with
extensive experience in vascular biology, Dr. Scott Johnstone, Dr. Robert Gourdie, and Dr. Brant Isakson, at
Virginia Tech’s Fralin Biomedical Research Institute (FBRI). The FBRI is home to research equipment including
but not limited to animal facilities, confocal microscopes, flow cytometers, and cell culture equipment. This state-
of-the-art research environment will allow for a detailed and mechanistic investigation. Ultimately, this study will
characterize a novel role for Cx43 in vascular EC. This project is designed to identify new potential therapeutic
targets in vascular disease that will promote the mission of the NIH to enhance patient health and to promote
longer life free of illness.
|| 项目摘要。
冠状动脉和隐静脉等血管的内皮伤口愈合受损是主要的原因
确定延迟性冠状动脉血栓形成的机制。
内皮修复对于改善血管通畅和患者生存率至关重要。
专注于识别正常内皮愈合的调节因子并了解这些因子是如何发挥作用的
先前的研究表明,当愈合受损时,连接蛋白 43 (Cx43) 间隙连接可能会失调。
然而,连接蛋白 43 在内皮细胞 (EC) 愈合中的具体作用尚不清楚。
该提案中的初步数据表明,结扎诱导的血管损伤会促进
小鼠主动脉和颈动脉受损区域周围 EC Cx43 的表达。
间隙连接细胞内通讯由 Cx43 C 末端的磷酸化控制。
数据表明,Cx43 丝氨酸 368 处的特异性磷酸化与间隙连接闭合相关,
Cx43-s368 存在于体内 EC 伤口愈合的最后阶段,也降低了伤口闭合率。
这些发现为 Cx43 表达和通道功能的假设提供了依据。
对于大动脉 EC 伤口愈合至关重要 该提案的目的是确定连接蛋白 43 在大动脉中的作用。
内皮伤口愈合(目标 1),研究 Cx43 的缺失是否会限制体内愈合(目标 1),并测试通道是否
功能,由翻译后修饰调节,改善/延迟血管修复(目标 2)。
将使用我开发的小鼠颈动脉 EC 损伤生存手术来完成,这将允许
用于评估愈合过程中颈动脉 EC 中的 Cx43 表达。
药理学策略将用于改变小鼠损伤模型中的 Cx43 表达和磷酸化
在培养的人类 EC 中,这些修饰对 EC 愈合速度和质量的影响将是
此外,RNAseq 方法将用于识别 Cx43 间隙连接依赖性信号传导。
这些目标将在研究人员的指导下实现。
Scott Johnstone 博士、Robert Gourdie 博士和 Brant Isakson 博士在血管生物学方面拥有丰富的经验
弗吉尼亚理工大学弗拉林生物医学研究所 (FBRI) 拥有包括以下在内的研究设备。
但不限于动物设施、共聚焦显微镜、流式细胞仪和细胞培养设备。
最先进的研究环境将允许进行详细和机械的调查。
表征 Cx43 在血管 EC 中的新作用 该项目旨在确定新的潜在治疗方法。
血管疾病的目标将促进 NIH 的使命,即增强患者健康并促进
无病长寿。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Meghan Sedovy其他文献
Meghan Sedovy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
人和小鼠中新冠病毒RBD的免疫原性表位及其互作抗体的表征和结构组学规律的比较研究
- 批准号:32371262
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于吡啶盐的可裂解抗体-药物偶联方法研究
- 批准号:22307081
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TFAM条件性敲除重塑树突状细胞免疫代谢增强PD-1抗体抗肿瘤作用的机制研究
- 批准号:82303723
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
广谱中和埃博拉病毒的纳米抗体研发以及中和机制研究
- 批准号:82302522
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新细胞因子FAM19A4联合CTLA-4抗体在肿瘤治疗的功能和机制研究
- 批准号:32370967
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Vascular Pathophysiology and History Core (VPHC)
血管病理生理学和病史核心 (VPHC)
- 批准号:
7662920 - 财政年份:2009
- 资助金额:
$ 4.25万 - 项目类别:
Therapeutic Modulation of Endothelial Cell Tetrahydrobiopterin
内皮细胞四氢生物蝶呤的治疗调节
- 批准号:
8379505 - 财政年份:
- 资助金额:
$ 4.25万 - 项目类别: